KUALA LUMPUR, Malaysia, March 21, 2016 (GLOBE NEWSWIRE) — Jeffrey Scott Yablon has received an Industry Recognition Award from Clinical Research Malaysia for his outstanding efforts in promoting Malaysia as a preferred destination for Industry Sponsored Research (ISR).
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/528a88b7-a898-4d3f-840e-ec343f0b0002
“I’m honored to have been recognized by Clinical Research Malaysia with this award,” said Yablon. “Expanding business in Malaysia has opened up multiple opportunities for many. Malaysia offers unique benefits to the clinical research industry, and I’m truly honored to have been recognized for my efforts on behalf of the region.”
At CRM Industry Dialogue held on March 16, 2016, Yablon was recognized for his dual efforts in promoting clinical research in Malaysia and developing the clinical research ecosystem in the country.
Yablon, who heads the Asia/Pacific operations for InClinica – a global clinical CRO – has more than 20 years of experience in life science management. A long-time advocate of expanding business opportunities in Asia, Yablon has also been responsible for developing a clinical research training and certificate program for InClinica.
Yablon has a B.A. degree from Stockton University, an M.S. in Clinical Pharmacology from Stony Brook University and an EMBA in International Business Management from Fairleigh Dickinson University.
CONTACT: Contact: John Reynolds + 1 610-228-0730 [email protected]